V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004420 | 280003073 | 1.76 | 75.2 | Neo-adjuvant (N) | 2015-10-09 | 2015-10-20 | EOX | N | N | 280027312 | EOX |
| 280004421 | 280003073 | null | 59 | Adjuvant (A) | 2016-06-04 | 2016-06-21 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | Y | 280027312 | NOT MATCHED |
| 280004422 | 280003074 | 1.67 | 63.8 | Curative (C) | 2018-05-25 | 2018-06-12 | EW EuroEwing 2012 Arm B VDC | N | Y | 280027315 | TRIAL |
| 280004423 | 280007549 | null | 81 | Curative (C) | 2014-09-05 | 2014-09-05 | Carboplatin AUC 6 - 10 | N | N | 280027316 | CARBOPLATIN |
| 280004424 | 280003075 | 1.63 | 63.3 | Curative (C) | 2013-07-20 | 2013-08-11 | CARBOPLATIN + RT | N | Y | 280027317 | CARBOPLATIN + RT |
| 280004425 | 280003075 | 1.63 | 72 | Curative (C) | null | 2015-06-30 | Cetuximab 7 day (Cycle 1) | 02 | null | 280027317 | CETUXIMAB |
| 280004426 | 280003075 | null | 109.6 | Curative (C) | 2017-10-10 | 2017-11-07 | EOX | 02 | N | 280027317 | EOX |
| 280004427 | 280003075 | 1.61 | 7.9 | Curative (C) | 2013-12-14 | 2013-12-15 | STS Non-Rhabdo EpSSG 2005 IVA | 01 | null | 280027317 | NOT MATCHED |
| 280004428 | 280003076 | 1.68 | null | Curative (C) | 2016-04-26 | 2016-04-29 | Trial Unspecified | N | N | 280027323 | TRIAL |
| 280004429 | 280003077 | 1.62 | 78 | Neo-adjuvant (N) | 2017-06-01 | 2017-06-04 | CARBOPLATIN + RT | N | N | 280027324 | CARBOPLATIN + RT |
| 280004430 | 280007551 | 1.85 | 92.6 | Palliative (P) | 2016-08-08 | 2016-08-09 | EOX | N | N | 280027325 | EOX |
| 280004431 | 280003078 | 1.7 | 103.7 | Curative (C) | 2016-02-19 | 2016-02-29 | Cetuximab 7 day (Cycle 1) | N | Y | 280027329 | CETUXIMAB |
| 280004432 | 280003078 | 0 | 43.3 | Adjuvant (A) | 2017-06-19 | 2017-06-19 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | 280027329 | NOT MATCHED |
| 280004433 | 280003079 | 1.6 | 71 | Adjuvant (A) | 2014-10-23 | 2014-11-05 | Cetuximab 7 day (Cycle 1) | N | N | 280027332 | CETUXIMAB |
| 280004434 | 280003079 | 1.55 | null | Adjuvant (A) | 2015-12-13 | 2015-12-14 | Carboplatin + Etoposide IV 3 day | null | null | 280027332 | CARBOPLATIN + ETOPOSIDE |
| 280004435 | 280003080 | 1.8 | 84.9 | Curative (C) | null | 2013-08-18 | EOX | Y | null | 280027339 | EOX |
| 280004436 | 280003080 | 1.73 | 55.6 | Curative (C) | 2013-10-19 | 2013-10-21 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027339 | CISPLATIN + GEMCITABINE |
| 280004437 | 280003081 | 1.62 | 91.2 | Palliative (P) | 2014-09-20 | 2014-09-23 | CARBOPLATIN + RT | N | Y | 280027342 | CARBOPLATIN + RT |
| 280004438 | 280003081 | 1.65 | null | Neo-adjuvant (N) | 2015-10-24 | 2015-11-19 | Cetuximab 7 day (Cycle 1) | N | Y | 280027342 | CETUXIMAB |
| 280004439 | 280003082 | 1.69 | 73 | Curative (C) | 2017-01-28 | 2017-01-29 | Carboplatin + Etoposide iv&po | N | N | 280027344 | CARBOPLATIN + ETOPOSIDE |
| 280004440 | 280003082 | 1.63 | 48.7 | Palliative (P) | 2016-01-25 | 2016-02-15 | CETUXIMAB | 02 | N | 280027344 | CETUXIMAB |
| 280004441 | 280003082 | 1.73 | 92.6 | Curative (C) | 2015-08-27 | 2015-09-17 | CETUXIMAB | 02 | N | 280027344 | CETUXIMAB |
| 280004442 | 280003083 | 1.5 | 59.5 | Palliative (P) | 2017-10-26 | 2017-11-22 | Carboplatin AUC 2 - 5 | N | Y | 280027348 | CARBOPLATIN |
| 280004443 | 280003083 | null | 75.6 | Curative (C) | 2015-05-23 | 2015-05-26 | EOX | N | N | 280027348 | EOX |
| 280004444 | 280003084 | 1.7 | 92.3 | Curative (C) | 2017-12-16 | 2018-01-01 | Carboplatin + Etoposide IV 3 day | 02 | N | 280027352 | CARBOPLATIN + ETOPOSIDE |
| 280004445 | 280003084 | 1.82 | 101.5 | Curative (C) | 2015-01-01 | 2015-01-21 | Cetuximab 7 day (Cycle 1) | N | N | 280027352 | CETUXIMAB |
| 280004446 | 280003084 | 1.17 | 69.6 | Curative (C) | 2013-10-03 | 2013-10-06 | Carboplatin AUC 2 - 5 | 02 | N | 280027352 | CARBOPLATIN |
| 280004447 | 280003085 | 1.58 | 62.2 | Palliative (P) | 2016-08-15 | 2016-08-20 | EW EuroEwing 2012 Arm B VDC | N | Y | 280027356 | TRIAL |
| 280004448 | 280007559 | 1.5 | 65.2 | Curative (C) | 2017-06-15 | 2017-07-02 | CARBOPLATIN + ETOPOSIDE | 02 | Y | 280027357 | CARBOPLATIN + ETOPOSIDE |
| 280004449 | 280007559 | 1.79 | null | null | 2016-02-09 | 2016-02-16 | EW EuroEwing 2012 Arm B VDC | 02 | Y | 280027357 | TRIAL |
| 280004450 | 280007559 | 1.69 | 102 | Curative (C) | 2014-01-17 | 2014-01-24 | Carboplatin AUC 2 - 5 | N | N | 280027357 | CARBOPLATIN |
| 280004451 | 280003086 | null | 97.9 | Neo-adjuvant (N) | 2014-03-05 | 2014-03-26 | CETUXIMAB | N | N | 280027367 | CETUXIMAB |
| 280004452 | 280007560 | null | null | Palliative (P) | 2015-06-14 | 2015-06-15 | EW EuroEwing 2012 Arm B VDC | N | Y | 280027368 | TRIAL |
| 280004453 | 280003087 | 1.93 | 83.5 | Curative (C) | null | 2013-03-01 | CETUXIMAB | null | null | 280027369 | CETUXIMAB |
| 280004454 | 280007561 | 1.58 | 60.5 | Curative (C) | 2016-12-18 | 2016-12-20 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 280027375 | CISPLATIN + GEMCITABINE |
| 280004455 | 280007561 | 1.9 | 75 | Curative (C) | 2015-08-24 | 2015-09-06 | Carboplatin AUC 6 - 10 | 02 | N | 280027375 | CARBOPLATIN |
| 280004456 | 280007561 | 1.73 | 109.2 | Curative (C) | 2015-04-27 | 2015-04-28 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 280027375 | CISPLATIN + GEMCITABINE |
| 280004457 | 280007561 | 1.5 | 61.7 | Curative (C) | null | 2015-05-16 | Carboplatin AUC 2 - 5 | y | N | 280027375 | CARBOPLATIN |
| 280004458 | 280011828 | 1.75 | null | Curative (C) | 2014-12-07 | 2014-12-11 | Trial Unspecified | N | N | 280027379 | TRIAL |
| 280004459 | 280011828 | 0.81 | 58 | Palliative (P) | 2014-03-25 | 2014-04-20 | STS Rhabdomyosarcoma RMS 2005 VAVV | N | N | 280027379 | NOT MATCHED |
| 280004464 | 280003089 | 1.8 | 91 | Curative (C) | 2013-12-25 | 2013-12-25 | CARBOPLATIN + RT | N | N | 280027388 | CARBOPLATIN + RT |
| 280004465 | 280003089 | 1.8 | null | Disease modification (D) | 2014-12-16 | 2014-12-29 | CISPLATIN + GEMCITABINE | N | N | 280027388 | CISPLATIN + GEMCITABINE |
| 280004466 | 280003090 | 1.61 | 72.9 | Curative (C) | 2014-12-07 | 2014-12-24 | Cetuximab 7 day (>Cycle 2) | N | N | 280027391 | CETUXIMAB |
| 280004467 | 280003090 | 1.82 | 83.5 | Curative (C) | 2013-06-18 | 2013-07-06 | Carboplatin AUC 6 - 10 | N | N | 280027391 | CARBOPLATIN |
| 280004468 | 280003090 | null | null | Adjuvant (A) | 2017-06-26 | 2017-06-26 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027391 | CISPLATIN + GEMCITABINE |
| 280004469 | 280003090 | 1.72 | null | Neo-adjuvant (N) | 2014-12-09 | 2014-12-10 | Cetuximab 7 day (Cycle 1) | 02 | Y | 280027391 | CETUXIMAB |
| 280004470 | 280011557 | null | 35.5 | Curative (C) | 2013-09-18 | 2013-09-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027396 | CISPLATIN + GEMCITABINE |
| 280004471 | 280003091 | 0 | null | Curative (C) | 2015-11-27 | 2015-11-27 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | Y | 280027397 | NOT MATCHED |
| 280004472 | 280003091 | 1.78 | null | Curative (C) | 2014-08-02 | 2014-08-02 | EW EuroEwing 2012 Arm B VDC | N | Y | 280027397 | TRIAL |
| 280004473 | 280003092 | 1.59 | 53.8 | Curative (C) | 2014-09-03 | 2014-09-03 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 280027400 | NOT MATCHED |